Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide (Q62813837)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide
clinical trial

    Statements

    Phase II Study of Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide Containing Chemotherapy: Menstruation Outcome (English)
    0 references
    March 2018
    0 references
    March 2020
    0 references
    100
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit